Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Vitamin E - Nutraceuticals World

What are you searching for?

Sign in
Research

Vitamin E

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

Indication: Heart disease and cancer

Source: Circulation, 2003;108:802-807.

Research: The extended Heart Outcomes Prevention Evaluation (HOPE-TOO) trial studied 9541 heart disease patients, who were administered either angiotensin-converting enzyme (ACE) inhibitor ramipril or vitamin E. Researchers examined the effects of both of these treatments against a placebo group to see their effects on the reduced risk of heart attack, stroke or cardiovascular death in high risk patients.

Results: While the ramipril testing was stopped early due to clearly positive results, the vitamin E study continued to its term. After a seven-year intervention, 21% of patients receiving the supplement experienced heart attack, stroke or cardiovascular death compared to approximately 21% of patients taking placebo. Approximately 15% of those taking vitamin E had a heart attack compared to 14% of those on placebo, while almost 6% of the vitamin E patients had a stroke compared to 5% of those on placebo. Just over 10% of the patients on vitamin E died from cardiovascular reasons compared with about 10% of those on placebo. Researchers also investigated the effects of vitamin E on cancer but there did not appear to be any statistical differences between the vitamin E group and the placebo group.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters